# RUFINAMIDE
> **ANDA216841** · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD III · Approved 2023-12-05
## Drug
- **FDA Application Number:** ANDA216841
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RUFINAMIDE
- **Generic name:** RUFINAMIDE
- **Active ingredients:** RUFINAMIDE
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** HETERO LABS LTD III
- **Manufacturer:** Camber Pharmaceuticals, Inc.
- **First approval:** 2023-12-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216841)
---
*AI Analytics · CC0 1.0*